("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today announced that it has received final approval from the U.S.

In the span of a mere thirty days, disastrous events have taken place with devastating consequences for workers and communities.

Last week, EllisDon Middle East held their annual general meeting in Dubai.

Rio Tinto, together with the Haisla First Nation and the Cheslatta Carrier Nation, have reached a key milestone in the development of the C$600-M Kemano Second Tunnel (T2) project with the unveiling of tl’ughus, the tunnel boring machine (TBM) that will be used to dig the 16 km-long second tunnel.

Sunnybrook researchers are investigating novel and innovative ways to help people suffering from treatment-resistant post-traumatic stress disorder (PTSD) with the help of a $1.25 million grant through the Government of Canada’s Veteran and Family Well-Being Fund.

Ryerson University ranks in the Greater Toronto’s Top Employers Competition for a fifth straight year.

Emily Morrison (Occupational and Public Health '18) was cited as a Global Winner at the Global Undergraduate Summit in Dublin, Ireland in November.

AMAPCEO members will by now have seen the Secretary of Cabinet’s memo on this matter.

There will be a series of downtown road closures and restrictions beginning at 5 p.m.

51st Canadian Mineral Processors Conference